Outset Medical Inc
OM15.110USD
+0.070+0.47%
交易中 （美東）報價延遲15分鐘
267.78M總市值
虧損本益比TTM
關於 Outset Medical Inc 公司
Outset Medical, Inc. 是一家醫療技術公司。該公司提供 Tablo 血液透析系統 (Tablo)，這是一種用於血液透析的單一企業解決方案，由一個緊湊型控制檯組成，該控制檯集成了水淨化、按需透析液生產和先進的軟件及連接功能。該公司從頭開始設計 Tablo，使其成爲一種單一企業解決方案，可在整個護理過程中使用，讓幾乎任何人都可以隨時隨地進行透析。Tablo 系統由 Tablo 控制檯、Tablo 墨盒和 Tablo 數據生態系統等組件組成。Tablo 控制檯是一種緊湊、移動且多功能的機器，由集成的水淨化、按需透析液生產系統和帶 3D 動畫的觸摸屏界面組成。它還提供各種關鍵平臺，例如面向客戶的門戶 TabloHub、面向患者的門戶 MyTablo 和內部數據分析平臺 TabloDash。
公司簡介
公司代碼OM
公司名稱Outset Medical Inc
上市日期Sep 15, 2020
CEOMs. Leslie L. Trigg
員工數量354
證券類型Ordinary Share
年結日Sep 15
公司地址3052 Orchard Drive
城市SAN JOSE
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編95134
電話16692318200
網址https://outsetmedical.com/
公司代碼OM
上市日期Sep 15, 2020
CEOMs. Leslie L. Trigg
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
69.22K
+1580.17%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
35.25K
+532.30%
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
22.95K
+64.31%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
10.25K
+706.77%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
9.22K
+3711.98%
Mrs. Brittni Mcgill
Mrs. Brittni Mcgill
Chief Nursing Officer
Chief Nursing Officer
--
--
Mr. John L. Brottem
Mr. John L. Brottem
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. D. Keith Grossman
Mr. D. Keith Grossman
Lead Independent Director
Lead Independent Director
--
--
Ms. Andrea L. Saia
Ms. Andrea L. Saia
Independent Director
Independent Director
--
--
Ms. Renee M. Gaeta, CPA
Ms. Renee M. Gaeta, CPA
Chief Financial Officer
Chief Financial Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
69.22K
+1580.17%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
35.25K
+532.30%
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
22.95K
+64.31%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
10.25K
+706.77%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
9.22K
+3711.98%
Mrs. Brittni Mcgill
Mrs. Brittni Mcgill
Chief Nursing Officer
Chief Nursing Officer
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Consumables
14.20M
47.74%
Services and other revenue
8.46M
28.43%
Consoles
7.09M
23.83%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
Consumables
14.20M
47.74%
Services and other revenue
8.46M
28.43%
Consoles
7.09M
23.83%
股東統計
更新時間: 6月14日 週六
更新時間: 6月14日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
14.55%
Durable Capital Partners LP
9.82%
Alyeska Investment Group, L.P.
9.61%
PFM Health Sciences, LP
9.51%
T. Rowe Price Investment Management, Inc.
9.05%
Other
47.47%
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
14.55%
Durable Capital Partners LP
9.82%
Alyeska Investment Group, L.P.
9.61%
PFM Health Sciences, LP
9.51%
T. Rowe Price Investment Management, Inc.
9.05%
Other
47.47%
股東類型
持股股東
佔比
Hedge Fund
40.58%
Investment Advisor
31.55%
Investment Advisor/Hedge Fund
9.99%
Private Equity
4.70%
Individual Investor
2.08%
Venture Capital
0.94%
Corporation
0.63%
Research Firm
0.28%
Bank and Trust
0.12%
Other
9.13%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
347
16.11M
90.89%
+12.67M
2025Q1
363
14.91M
84.25%
+11.40M
2024Q4
375
22.97M
42.67%
-34.22M
2024Q3
383
28.58M
54.40%
-41.22M
2024Q2
397
50.60M
97.17%
-19.65M
2024Q1
406
52.26M
101.52%
-18.15M
2023Q4
416
54.21M
107.73%
-7.17M
2023Q3
407
56.98M
114.62%
-11.76M
2023Q2
399
56.04M
113.10%
-11.31M
2023Q1
408
55.02M
111.94%
-9.31M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Fidelity Management & Research Company LLC
2.58M
14.55%
+2.35M
+1040.39%
Mar 31, 2025
Durable Capital Partners LP
1.74M
9.82%
+1.74M
--
Mar 31, 2025
Alyeska Investment Group, L.P.
1.70M
9.61%
+1.70M
--
Mar 31, 2025
PFM Health Sciences, LP
1.69M
9.51%
+1.69M
--
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.60M
9.05%
+1.39M
+659.32%
Mar 31, 2025
Woodline Partners LP
1.33M
7.48%
+1.33M
--
Mar 31, 2025
The Vanguard Group, Inc.
173.32K
0.98%
-602.00
-0.35%
Mar 31, 2025
MFS Investment Management
840.25K
4.74%
+840.25K
--
Mar 31, 2025
Perceptive Advisors LLC
833.33K
4.7%
+833.33K
--
Mar 31, 2025
Marshall Wace LLP
650.26K
3.67%
+650.26K
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Value ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
SPDR S&P Health Care Equipment ETF
0%
查看更多
iShares Micro-Cap ETF
佔比0.06%
iShares Russell 2000 Value ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
Avantis US Small Cap Equity ETF
佔比0.01%
SPDR S&P Health Care Equipment ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
公告日期
類型
比率
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
